meningioma

meningioma predicts individual-patient meningioma malignancy and survival outcomes using statistical models trained on the Surveillance, Epidemiology, and End Results (SEER) database.

Key Features:

• Data-Driven Predictions: Trains predictive models on 62,844 patients from the Surveillance, Epidemiology, and End Results (SEER) database.
• Advanced Statistical Models: Implements balanced logistic regression-random forest ensemble classifiers and proportional hazards models to identify predictive multivariate patterns.
• Clinical Variables Modeled: Correlates clinical variables such as tumor size, tumor location, and surgical procedures with malignancy and survival outcomes.
• Generalizability: Assesses model performance and generalizability across 16 SEER registries.

Scientific Applications:

• Individual-patient Prognosis: Provides individual-specific predictions of meningioma malignancy and survival to support prognosis and risk stratification.
• Integration with Multimodal Diagnostics: Can be incorporated into diagnostic frameworks alongside imaging and molecular biomarkers to improve diagnostic accuracy.
• Treatment Planning and Counseling: Informs treatment planning and patient counseling by supplying individualized risk estimates.

Methodology:

Models were trained on 62,844 SEER patients using balanced logistic regression-random forest ensemble classifiers and proportional hazards models to identify multivariate patterns relating clinical variables (tumor size, location, surgical procedures) to malignancy and survival, with assessment of generalizability across 16 SEER registries.